Immunobiology and pathology of chronic rejection.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Transplantation Proceedings

• Publication date

  1997-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0041-1345(96)00014-0PMID 9123163
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The UNOS Scientific Renal Transplant Registry.

  1999cited by this paper
• Identification of differentially expressed genes in rat aortic allograft vasculopathy.

  1996cited by this paper
• Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis.

  1996cited by this paper
• Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat.

  1996cited by this paper
• Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.

  1995cited by this paper
• Stabile D‐peptide analog of insulin‐like growth factor‐l inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat

  1995cited by this paper
• Effect of pravastatin on outcomes after cardiac transplantation.

  1995cited by this paper
• How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts.

  1995cited by this paper
• Chronic cardiac rejection: identification of five upregulated genes in transplanted hearts by differential mRNA display.

  1994cited by this paper
• Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity.

  1994cited by this paper
• Pathophysiology of vascular wall changes in chronic allograft rejection

  1993cited by this paper
• GLOMERULAR CAPILLARY PRESSURES IN LONG‐SURVIVING RAT RENAL ALLOGRAFTS

  1993cited by this paper
• Inhibition of graft arteriosclerosis by modulation of the inflammatory response.

  1993cited by this paper
• Somatostatin analog Lanreotide inhibits myocyte replication and several growth factors in allograft arteriosclerosis

  1993cited by this paper

• Development of Transplant Arteriosclerosis: Effect of Timing of Infection and Recipient Genotype

  2018cites this paper
• Chapter 6 Origin of Endothelium and Alpha-Actin Positive Smooth Muscle Cells in Transplant Arteriosclerosis

  2018cites this paper
• Expression of NO Synthase Under Medication with Cyclosporine A, Mycophenolate Mofetil, and Tacrolimus during Development of Transplant Vasculopathy on Rat Cardiac Allograft.

  2016cites this paper
• Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C‐coinfected patients

  2007cites this paper
• Do we have a new early marker of chronic transplant dysfunction now?

  2002cites this paper
• Use of recombinase activation gene-2 deficient mice to ascertain the role of cellular and humoral immune responses in the development of chronic rejection.

  2002cites this paper
• Transplant arteriosclerosis

  2001cites this paper
• INTRATHYMIC IMMUNE MODULATION PREVENTS ACUTE REJECTION BUT NOT THE DEVELOPMENT OF GRAFT ARTERIOSCLEROSIS (CHRONIC REJECTION)1

  2001cites this paper
• Potential therapeutic interventions to avoid or treat chronic allograft dysfunction.

  2001cites this paper
• Vascular adhesion protein‐1 (VAP‐1) mediates lymphocyte‐endothelial interactions in chronic kidney rejection

  2001cites this paper
• Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis.

  2001cites this paper
• Current treatment practice in immunosuppression

  2000cites this paper
• Recipient origin of neointimal vascular smooth muscle cells in cardiac allografts with transplant arteriosclerosis.

  2000cites this paper
• Correlation between angiotensin-converting enzyme gene insertion/deletion polymorphism and kidney graft long-term outcome in pediatric recipients: a single-center analysis.

  1999cites this paper
• Expression of heat shock proteins 60 and 70 is a marker of preservation-induced endothelial cell activation.

  1999cites this paper
• On the edge: the physiological and pathophysiological role of chemokines during inflammatory and immunological responses.

  1999cites this paper
• Hyaluronsäure als Verlaufsparameter im Rahmen der Lebertransplantation

  1998cites this paper
• Organ transplantation in the twenty-first century.

  1998cites this paper
• Concepts and Mechanisms of Immune Activation, Graft Rejection, Immunosuppression, and Tolerance

  1998cites this paper
• The significance of antibody production in human renal transplantation

  1997cites this paper
• Transplant arteriosclerosis

  year unknowncites this paper